» Articles » PMID: 9585235

Characterization of a Recombinant Plant Monoclonal Secretory Antibody and Preventive Immunotherapy in Humans

Overview
Journal Nat Med
Date 1998 May 19
PMID 9585235
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

A functional comparison was made between a monoclonal secretory antibody generated in transgenic plants and its parent murine IgG antibody.The affinity constants of both antibodies for a Streptococcus mutans adhesion protein were similar. However the secretory antibody had a higher functional affinity due to its dimeric structure. In the human oral cavity, the secretory antibody survived for up to three days, compared with one day for the IgG antibody. The plant secretory antibody afforded specific protection in humans against oral streptococcal colonization for at least four months. We demonstrate that transgenic plants can be used to produce high affinity, monoclonal secretory antibodies that can prevent specific microbial colonization in humans. These findings could be extended to the immunotherapeutic prevention of other mucosal infections in humans and animals.

Citing Articles

Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems.

Bharathi J, Suresh P, Prakash M, Muneer S Heliyon. 2024; 10(18):e37634.

PMID: 39309966 PMC: 11416299. DOI: 10.1016/j.heliyon.2024.e37634.


Recombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2.

Goritzer K, Groppelli E, Grunwald-Gruber C, Figl R, Ni F, Hu H Mol Ther. 2024; 32(3):689-703.

PMID: 38268188 PMC: 10928148. DOI: 10.1016/j.ymthe.2024.01.025.


Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination.

Heaney C, Hempel H, DeRosa K, Pinto L, Mantis N Clin Chem. 2023; 70(4):589-596.

PMID: 38039096 PMC: 10987228. DOI: 10.1093/clinchem/hvad169.


Oral microbial interactions from an ecological perspective: a narrative review.

Fine D, Schreiner H Front Oral Health. 2023; 4:1229118.

PMID: 37771470 PMC: 10527376. DOI: 10.3389/froh.2023.1229118.


Delivery of biologics: Topical administration.

Kulchar R, Singh R, Ding S, Alexander E, Leong K, Daniell H Biomaterials. 2023; 302:122312.

PMID: 37690380 PMC: 10840840. DOI: 10.1016/j.biomaterials.2023.122312.